Evidence map›Paper›PMID 28848021›Full record

ArticleAntimicrobial agents and chemotherapy2017

Real-Time PCR Targeting the

L K Wong, P Hemarajata, O O Soge, R M Humphries, J D Klausner

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Resistance-Guided Therapy for Neisseria gonorrhoeae.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

L K WongEmory University School of Medicine, Atlanta, Georgia, USA.
P HemarajataDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.ORCID 0000-0001-6182-9136
O O SogeNeisseria Reference Laboratory, University of Washington Harborview Medical Center, Seattle, Washington, USA.ORCID 0000-0002-8504-2319
R M HumphriesDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA rhumphries@mednet.ucla.edu.
J D KlausnerDivision of Infectious Diseases, Center for World Health and Department of Epidemiology, David Geffen School of Medicine and Fielding School of Public Health, UCLA, Los Angeles, California, USA.
University of California, Los Angeles · USEmory University · USUniversity of Washington · US

Funding

Reducing excess broad-spectrum antibiotic use in gonorrheaR21AI117256 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI KLAUSNER, JEFFREY DAVID · 2016 to 2017
$424k
NIAID NIH HHS R21 AI117256
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AllelesAnti-Bacterial AgentsBacterial ProteinsCephalosporin ResistanceCephalosporinsDNA GyraseGonorrheaHumansLimit of DetectionMicrobial Sensitivity TestsMosaicismNeisseria gonorrhoeaeReal-Time Polymerase Chain ReactionSensitivity and SpecificityUnited StatesAnti-Bacterial AgentsBacterial ProteinsCephalosporinsDNA Gyraseantibiotic resistanceantimicrobial resistanceceftriaxonecephalosporinextended-spectrum cephalosporinsgonorrheamolecular methodsNeisseria gonorrhoeae

Identifiers

PMID28848021
PMCPMC5655115
OpenAlexW2747698602

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.